<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00937924</url>
  </required_header>
  <id_info>
    <org_study_id>HS 2007-5810</org_study_id>
    <nct_id>NCT00937924</nct_id>
  </id_info>
  <brief_title>Adjunct Sedatives in Procedures Involving Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP)</brief_title>
  <official_title>A Randomized, Double-Blinded, Placebo-Controlled Trial of Promethazine and Diphenhydramine as Adjunct Sedatives for Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare meperidine/midazolam with diphenhydramine,
      meperidine/midazolam with promethazine, and meperidine/midazolam with placebo as sedation
      methods. The investigators are interested to see whether adjunct sedatives (diphenhydramine
      and promethazine) will improve sedation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparing sedation techniques during invasive endoscopic procedures such as ERCP and EUS is a
      relatively unexplored area of clinical research. In particular, the effectiveness of adjunct
      sedatives such as diphenhydramine and promethazine during ERCP/EUS procedures has not been
      studied. Achieving a moderate sedation level may be ideal for ERCP/EUS procedures in order to
      provide adequate patient comfort, amnesia, and completion of intended endoscopic procedures.
      The relevance of further studies in this area is apparent. In terms of clinical practice;
      over-sedation can lead to decreased airway protection, longer post-procedural recovery times,
      and unnecessary drug cost; under-sedation can lead to patient anxiety, agitation, recall, and
      longer procedural time.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">September 2010</completion_date>
  <primary_completion_date type="Anticipated">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sedation Level</measure>
    <time_frame>Pre-Endoscopic Procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to achieve adequate level of sedation to begin procedure</measure>
    <time_frame>Pre-Endoscopic Procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time for Recovery</measure>
    <time_frame>Post-Endoscopic Procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Symptoms From Sedative Agents</measure>
    <time_frame>Pre/post Endoscopic Procedure</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">465</enrollment>
  <condition>Endoscopic Ultrasound (EUS)</condition>
  <condition>Endoscopic Retrograde Cholangiopancreatography (ERCP)</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control. Normal Saline Injections.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diphenhydramine injections given as adjunct sedative.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Promethazine given as an adjunct sedative.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline solution injections</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diphenhydramine</intervention_name>
    <description>Diphenhydramine injections</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Promethazine</intervention_name>
    <description>Promethazine</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing participants between 18 and 75 years of age who present for ERCP or EUS at
             H.H. Comprehensive Chao Digestive Disease Center.

        Exclusion Criteria:

          -  History of allergic or adverse reactions to midazolam, diphenhydramine, or
             promethazine.

          -  Acute asthma, narrow angle glaucoma, concurrent use of potent inhibitors of CYP3A4
             (amprenavir, atazanavir, or ritonavir), pregnancy, or the inability to consent.

          -  Patients with conditions that preclude safe conscious sedation will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Venkataraman Muthusamy, MD</last_name>
    <phone>714 456-5765</phone>
    <email>raman@uci.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Swapna Reddy, MD</last_name>
    <email>sbreddy@uci.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>H.H. Chao Comprehensive Digestive Disease Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2008</study_first_submitted>
  <study_first_submitted_qc>July 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <last_update_submitted>February 10, 2011</last_update_submitted>
  <last_update_submitted_qc>February 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Venkataraman Muthusamy</name_title>
    <organization>Department of Gastroenterology</organization>
  </responsible_party>
  <keyword>EUS</keyword>
  <keyword>ERCP</keyword>
  <keyword>Sedation Level</keyword>
  <keyword>Adverse Symptoms</keyword>
  <keyword>Recovery time</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Promethazine</mesh_term>
    <mesh_term>Hypnotics and Sedatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

